Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dexian Zheng

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Journal of Virology|December 20, 2013
Human T-cell leukemia virus type 1 Tax-deregulated autophagy pathway and c-FLIP expression contribute to resistance against death receptor-mediated apoptosisWeimin Wang, Jiansuo Zhou, Juan Shi, et al.
Theranostics|August 15, 2019
A novel anti-DR5 antibody-drug conjugate possesses a high-potential therapeutic efficacy for leukemia and solid tumorsShuyong Zhang, Chao Zheng, Wan Zhu, et al.
Molecular Oncology|January 14, 2015
RIP1 modulates death receptor mediated apoptosis and autophagy in macrophagesZhenyu Yao, Peng Zhang, Hui Guo, et al.
IUBMB Life|July 28, 2017
A novel humanized anti-tumor necrosis factor-related apoptosis-inducing ligand-R2 monoclonal antibody induces apoptotic and autophagic cell deathLongfei Chen, Yuhe Qiu, Zhenliang Hao, et al.
Proteomics|November 11, 2005
Human urine proteome analysis by three separation approachesWei Sun, Fuxin Li, Shuzhen Wu, et al.
Oncogene|May 11, 2018
GALNT5 uaRNA promotes gastric cancer progression through its interaction with HSP90Hui Guo, Lianmei Zhao, Bianhua Shi, et al.
Cancer Letters|February 11, 2011
Adeno-associated virus-mediated anti-DR5 chimeric antibody expression suppresses human tumor growth in nude miceFujia Lv, Yuhe Qiu, Yaxi Zhang, et al.
BMC Cancer|February 5, 2011
Synergistic antitumor effect of AAV-mediated TRAIL expression combined with cisplatin on head and neck squamous cell carcinomaMinghong Jiang, Zheng Liu, Yang Xiang, et al.
The Journal of Biological Chemistry|January 29, 2010
Targeting a novel N-terminal epitope of death receptor 5 triggers tumor cell deathPeng Zhang, Yong Zheng, Juan Shi, et al.
Theranostics|September 14, 2017
Combination of AAV-TRAIL with miR-221-Zip Therapeutic Strategy Overcomes the Resistance to TRAIL Induced Apoptosis in Liver CancerSisi Ma, Jiazeng Sun, Yabin Guo, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Journal of Virology|December 20, 2013
Human T-cell leukemia virus type 1 Tax-deregulated autophagy pathway and c-FLIP expression contribute to resistance against death receptor-mediated apoptosisWeimin Wang, Jiansuo Zhou, Juan Shi, et al.
Theranostics|August 15, 2019
A novel anti-DR5 antibody-drug conjugate possesses a high-potential therapeutic efficacy for leukemia and solid tumorsShuyong Zhang, Chao Zheng, Wan Zhu, et al.
Molecular Oncology|January 14, 2015
RIP1 modulates death receptor mediated apoptosis and autophagy in macrophagesZhenyu Yao, Peng Zhang, Hui Guo, et al.
IUBMB Life|July 28, 2017
A novel humanized anti-tumor necrosis factor-related apoptosis-inducing ligand-R2 monoclonal antibody induces apoptotic and autophagic cell deathLongfei Chen, Yuhe Qiu, Zhenliang Hao, et al.
Proteomics|November 11, 2005
Human urine proteome analysis by three separation approachesWei Sun, Fuxin Li, Shuzhen Wu, et al.
Oncogene|May 11, 2018
GALNT5 uaRNA promotes gastric cancer progression through its interaction with HSP90Hui Guo, Lianmei Zhao, Bianhua Shi, et al.
Cancer Letters|February 11, 2011
Adeno-associated virus-mediated anti-DR5 chimeric antibody expression suppresses human tumor growth in nude miceFujia Lv, Yuhe Qiu, Yaxi Zhang, et al.
BMC Cancer|February 5, 2011
Synergistic antitumor effect of AAV-mediated TRAIL expression combined with cisplatin on head and neck squamous cell carcinomaMinghong Jiang, Zheng Liu, Yang Xiang, et al.
The Journal of Biological Chemistry|January 29, 2010
Targeting a novel N-terminal epitope of death receptor 5 triggers tumor cell deathPeng Zhang, Yong Zheng, Juan Shi, et al.
Theranostics|September 14, 2017
Combination of AAV-TRAIL with miR-221-Zip Therapeutic Strategy Overcomes the Resistance to TRAIL Induced Apoptosis in Liver CancerSisi Ma, Jiazeng Sun, Yabin Guo, et al.
Pageof 7